Article
The contribution of mechanistic understanding to phenotypic screening for first-in-class medicines.
Journal of biomolecular screening - 1 Dec 2013
Swinney David C
Abstract excerpt
The level of mechanistic understanding required for drug discovery is a central feature of most strategies. However, an understanding of mechanism is not required for regulatory approval. This paradox is particularly relevant to the role of phenotypic assays in drug discovery. A recent analysis revealed that phenotypic drug discovery strategies were more successful for first-in-class medicines, whereas...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
